Get informed when a big investor buys or sells
+ FollowOvervalued by 151.8% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $7.02 Million |
|---|---|
| Enterprise Value | $11.83 Million |
| Earnings per Share | $0 |
| Beta | 0.07 |
| Outstanding Shares | 603,491,000 |
| P/E Ratio | -16.67 |
|---|---|
| PEG | 29.31 |
| Price to Sales | - |
| Price to Book Ratio | -0.01 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -5.21 |
| Enterprise Value to Net Income | -18 |
| Total Debt to Enterprise | 0.41 |
| Debt to Equity | -0.72 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
PreveCeutical Medical Inc. is a health sciences firm dedicated to creating preventative and therapeutic solutions, employing compounds that are either organic or identical to natural substances. Its robust product pipeline features the C...